Inventor · disambiguated record
Raquel Hontecillas
Also filed as: HONTECILLAS RAQUEL
31 granted patents·11 pending applications·153 citations·filing 2007–2024
96Inventor score
Files withLANDOS BIOPHARMA INC24NIMMUNE BIOPHARMA INC7VIRGINIA TECH INTELL PROP5BASSAGANYA-RIERA JOSEP3NIMML INST2
Top patents by PatentIndex Score
42 records- 0196US10849895B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2020·Granted Dec 1, 2020·4 cites·40 claims
- 0295US10493072B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2018·Granted Dec 3, 2019·14 cites·27 claims
- 0395US10201538B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2018·Granted Feb 12, 2019·12 cites·16 claims
- 0495US10028950B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2017·Granted Jul 24, 2018·15 cites·18 claims
- 0595US9839635B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·16 cites·22 claims
- 0695US9556146B2Lanthionine synthetase C-like 2-based therapeuticsBIOTHERAPEUTICS INC·Filed 2015·Granted Jan 31, 2017·23 cites·24 claims
- 0795US7741367B2Method of using abscisic acid to treat diseases and disordersVIRGINIA TECH INTELL PROP·Filed 2007·Granted Jun 22, 2010·33 cites·6 claims
- 0894US11117881B2Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameLANDOS BIOPHARMA INC·Filed 2020·Granted Sep 14, 2021·2 cites·38 claims
- 0993US10682349B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2019·Granted Jun 16, 2020·8 cites·36 claims
- 1091US10487057B1NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2019·Granted Nov 26, 2019·5 cites·1 claims
- 1189US11180473B2PLXDC2 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Nov 23, 2021·2 cites·55 claims
- 1287US11197891B2Therapies with lanthionine C-like protein 2 ligands and cells prepared therewithLANDOS BIOPHARMA INC·Filed 2018·Granted Dec 14, 2021·2 cites·23 claims
- 1387US10676436B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2019·Granted Jun 9, 2020·2 cites·38 claims
- 1485US11548885B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Jan 10, 2023·1 cites·29 claims
- 1584US12502388B2Lanthionine synthetase C-like 2-based therapeuticsNIMMUNE BIOPHARMA INC·Filed 2022·Granted Dec 23, 2025·0 cites·20 claims
- 1684US2025163017A1Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameNIMMUNE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1783US9101573B2Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disordersBASSAGANYA-RIERA JOSEP·Filed 2011·Granted Aug 11, 2015·10 cites·10 claims
- 1882US8367727B2Method of using abscisic acid to treat diseases and disordersVIRGINIA TECH INTELL PROP·Filed 2010·Granted Feb 5, 2013·3 cites·8 claims
- 1981US2024166601A1Nlrx1 ligandsLANDOS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2080US2025163377A1Therapies with lanthionine c-like protein 2 ligands and cells prepared therewithNIMMUNE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2178US11571419B2Lanthionine synthetase C-like 2-based therapeuticsLANDOS BIOPHARMA INC·Filed 2020·Granted Feb 7, 2023·0 cites·13 claims
- 2276US12145920B2Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameNIMMUNE BIOPHARMA INC·Filed 2022·Granted Nov 19, 2024·0 cites·19 claims
- 2375US11680045B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Jun 20, 2023·0 cites·21 claims
- 2475US11377437B2Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using sameLANDOS BIOPHARMA INC·Filed 2021·Granted Jul 5, 2022·0 cites·30 claims
- 2573US12281096B2Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)NIMMUNE BIOPHARMA INC·Filed 2022·Granted Apr 22, 2025·0 cites·16 claims
- 2673US8993624B2Method of preventing and treating inflammatory diseases and disorders with abscisic acidBASSAGANYA-RIERA JOSEP·Filed 2011·Granted Mar 31, 2015·1 cites·6 claims
- 2772US12145921B2Aromatic immunoregulatory compounds for treatment of inflammatory diseasesNIMML INST·Filed 2022·Granted Nov 19, 2024·0 cites·10 claims
- 2872US11492342B2Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)LANDOS BIOPHARMA INC·Filed 2021·Granted Nov 8, 2022·0 cites·15 claims
- 2972US2023192652A1Plxdc2 ligandsLANDOS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3071US12150961B2Therapies with lanthionine C-like protein 2 ligands and cells prepared therewithNIMMUNE BIOPHARMA INC·Filed 2021·Granted Nov 26, 2024·0 cites·15 claims
- 3170US12391673B2LANCL ligandsNIMMUNE BIOPHARMA INC·Filed 2022·Granted Aug 19, 2025·0 cites·26 claims
- 3270US11066364B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2020·Granted Jul 20, 2021·0 cites·30 claims
- 3370US2024368116A1Immunoregulatory compoundsNIMML INST·Filed 2024·Application pending·0 cites
- 3469US11597717B2Substituted imidazoles as PLXDC2 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Mar 7, 2023·0 cites·31 claims
- 3566US11459310B2LANCL ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Oct 4, 2022·0 cites·30 claims
- 3666US2023128450A1Nlrx1 ligandsLANDOS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3759US2024270743A1Tetrahydropyrazolopyridine-analog ligands of nlrx1 and uses thereofLANDOS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3857US2022152019A1Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of surface tissuesLANDOS BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3956US9119881B2Method of synergistically enhancing the therapeutic efficacy and safety of medication through a combination therapyVIRGINIA TECH INTELL PROP·Filed 2013·Granted Sep 1, 2015·0 cites·2 claims
- 4042US2010204188A1Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapyVIRGINIA TECH INTELL PROP·Filed 2010·Application pending·0 cites
- 4137US2015241448A1Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disordersBASSAGANYA-RIERA JOSEP·Filed 2015·Application pending·0 cites
- 4235US2011054033A1Methods of using abscisic acid for ameliorating hypertension and vascular inflammationVIRGINIA TECH INTELL PROP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Raquel Hontecillas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →